New study shows focal therapy matches surgery and radiation survival while reducing side effects in localized prostate cancer

Physicians remain split over focal therapy for localized prostate cancer, a technique that targets MRI‑visible lesions with heat, cold, or other energy sources instead of removing the entire gland.

A recent ten‑year study reported survival rates similar to those achieved with surgery or radiation, while patients experienced fewer urinary and sexual side effects.

Although the data are encouraging, treatment guidelines still label focal therapy as experimental, and broader adoption will depend on further evidence and consensus among urologic oncologists.